EpiScout
EpiScout Analysis Suite is a bioinformatics platform designed for researchers analyzing RNA modifications in clinical and biomedical studies.
Publisher review
EpiScout Analysis Suite is a bioinformatics platform designed for researchers analyzing RNA modifications in clinical and biomedical studies. It serves molecular biologists and epigenetics researchers who need to process input-limited RNA samples, particularly those working with the EpiPlex RNA Library Prep Kit. The software focuses on epitranscriptomic data, which includes chemical modifications affecting RNA function, with applications in cancer research, neurology, and drug development.
Its primary user base includes academic labs and pharmaceutical R&D teams investigating RNA-based biomarkers and therapeutic targets. The platform is part of a collaboration between DNAnexus and AlidaBio, integrating cloud-based scalability with specialized RNA modification analysis tools. EpiScout stands out for handling multiplexed data from scarce clinical samples, addressing a critical bottleneck in translational research where sample volume is often restricted.
The suite is tailored for studies requiring high-resolution mapping of modifications like m6A, m5C, and pseudouridine, which regulate gene expression and splicing events. Researchers benefit from its compatibility with AlidaBio's wet-lab workflows, creating an end-to-end solution from library prep to data visualization. The tool's development reflects growing demand for integrative platforms that bridge experimental and computational epitranscriptomics, particularly in precision medicine applications.
EpiScout's design prioritizes studies where RNA quantity is limiting, such as liquid biopsies or single-cell analyses, making it relevant for both discovery-phase research and clinical validation pipelines. The platform's cloud-native architecture via DNAnexus enables collaborative analysis across institutions while maintaining data security compliance for sensitive clinical datasets. Its adoption is increasing among researchers investigating RNA modification dynamics in disease progression and treatment response biomarkers.
EpiScout fills a niche in the epitranscriptomics toolchain by combining wet-lab compatibility with computational rigor, though its specialized focus means broader omics integration requires additional software. The suite's machine learning components target improved modification calling accuracy compared to conventional peak detection methods, addressing known challenges in low-input RNA modification profiling. As the field moves toward clinical applications, EpiScout's sensitivity benchmarks position it for studies requiring detection of rare modification events in complex biological samples. Its development roadmap emphasizes quantitative analysis of modification stoichiometry, a key requirement for understanding functional impacts of epitranscriptomic changes.
How it works
-
Multiplexed epitranscriptomic analysis
Processes input-limited clinical RNA samples down to 10ng input, enabling studies with scarce material like liquid biopsies or single cells.
-
Machine learning peak calling
Uses custom algorithms to distinguish true RNA modifications from noise, achieving 90% reproducibility in technical replicates.
-
Cloud-based visualization
Provides interactive browsers for modification patterns across transcripts, with genome browser integration for context.
-
EpiPlex kit integration
Direct compatibility with AlidaBio's library prep workflow reduces data processing artifacts from wet-lab steps.
-
Modification stoichiometry quantification
Calculates modification fractions per site using normalized read counts, critical for functional studies.
-
DNAnexus cloud hosting
Runs on HIPAA-compliant infrastructure with scalable compute for large cohort analyses.
-
Differential modification analysis
Identifies statistically significant changes between conditions using modified negative binomial models.
Strengths and trade-offs
Strengths
- Achieves 90% reproducibility in technical replicates for modification calling, critical for clinical validation studies.
- Processes RNA inputs as low as 10ng while maintaining >80% sensitivity for abundant modifications.
- Integrates directly with EpiPlex wet-lab workflows, reducing protocol-specific analysis artifacts.
- Cloud architecture enables collaborative analysis of sensitive clinical data with access controls.
Trade-offs
- Specialized for RNA modifications only, requiring additional tools for parallel DNA methylation or chromatin analysis.
- Lacks standalone installation option, mandating cloud access through DNAnexus platform.
- No public benchmarks against alternatives like MeRIP-seq or miCLIP for rare modification detection.
- Documentation focuses on EpiPlex users, creating a learning curve for other library prep methods.
Pricing context
Enterprise SaaS pricing via DNAnexus platform; academic discounts available but undisclosed base costs.
Getting started with EpiScout
-
Request access
Contact DNAnexus or AlidaBio to request EpiScout access. Provide institutional details and intended research use case for enterprise account setup.
-
Upload RNA-seq data
Transfer FASTQ files from EpiPlex or compatible RNA-seq runs to your DNAnexus project space. Organize samples by experimental condition for downstream analysis.
-
Select modification type
Choose target RNA modifications (m6A, m5C, pseudouridine) in the analysis module. Set detection thresholds based on expected modification abundance.
-
Run differential analysis
Execute the comparison pipeline between sample groups. Specify covariates and statistical parameters for modification change detection.
-
Visualize modification profiles
Explore results in the integrated genome browser. Export publication-ready plots of significant modification sites and stoichiometry measurements.
Frequently Asked Questions
What is EpiScout?
EpiScout is a bioinformatics platform for analyzing RNA modifications in clinical and biomedical research. It processes input-limited RNA samples, focusing on epitranscriptomic data, and is used in cancer research, neurology, and drug development. It integrates cloud-based scalability with specialized RNA modification analysis tools.
How does EpiScout handle RNA modifications?
EpiScout uses machine learning algorithms to accurately identify RNA modifications, achieving 90% reproducibility. It processes RNA samples as low as 10ng, making it suitable for scarce materials like liquid biopsies. The platform quantifies modification stoichiometry, crucial for understanding functional impacts in epitranscriptomics.
What are the applications of EpiScout in research?
EpiScout is used in cancer research, neurology, and drug development to analyze RNA modifications. It supports studies on RNA-based biomarkers and therapeutic targets, particularly in clinical validation pipelines and discovery-phase research, making it valuable for precision medicine applications.
Is EpiScout cloud-based?
Yes, EpiScout is cloud-based, hosted on the DNAnexus platform. This enables scalable, collaborative analysis of sensitive clinical data while maintaining HIPAA compliance. The cloud architecture supports large cohort analyses and integrates with AlidaBio's wet-lab workflows for seamless data processing.
What are the strengths of EpiScout?
EpiScout excels in reproducibility, achieving 90% accuracy in modification calling. It processes low RNA inputs (down to 10ng) with high sensitivity and integrates seamlessly with EpiPlex workflows. Its cloud-based architecture supports collaborative, secure analysis of clinical datasets.
What are the limitations of EpiScout?
EpiScout specializes in RNA modifications, requiring additional tools for DNA methylation or chromatin analysis. It lacks standalone installation, mandating cloud access via DNAnexus. Documentation focuses on EpiPlex users, creating a learning curve for those using other library prep methods.
Alternatives
How EpiScout compares
Direct head-to-head against 2 competitors. Picked by 7wData.
EpiScout
- Pricing
- Enterprise SaaS pricing via DNAnexus platform; academic discounts available but undisclosed base costs.
- Target
- EpiScout Analysis Suite is a bioinformatics platform designed for researchers analyzing RNA modifications in clinical and biomedical studies.
- Strength
- Achieves 90% reproducibility in technical replicates for modification calling, critical for clinical validation studies.
- Watch for
- Specialized for RNA modifications only, requiring additional tools for parallel DNA methylation or chromatin analysis.
DNAnexus
- Pricing
- Custom/Contact sales
- Target
- Precision health data analysis
- Deployment
- Cloud
- Strength
- Scalable multiomic data platform
- Watch for
- Complex pricing structure
AlidaBio EpiPlex
- Pricing
- Custom/Contact sales
- Target
- Epitranscriptomic research
- Deployment
- On-premise/Cloud
- Strength
- High-sensitivity RNA modification detection
- Watch for
- Requires bioinformatics expertise
User reviews
No user reviews yet. Be the first to write one.
Sources
Reporting on this tool draws on these publicly available sources.